These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Microalbuminuria in pregnancy as a predictor of preeclampsia and eclampsia. Salako BL, Olayemi O, Odukogbe AT, Adedapo KS, Aimakhu CO, Alu FE, Ola B. West Afr J Med; 2003 Dec; 22(4):295-300. PubMed ID: 15008291 [Abstract] [Full Text] [Related]
27. Selected local and peripheral intereactions of some cytokines in etiopathogenesis of preeclampsia. Bielecki DA, Terlikowski SJ, Południewski G, Bielecki M. Rocz Akad Med Bialymst; 2002 Sep; 47():5-20. PubMed ID: 12533944 [Abstract] [Full Text] [Related]
28. ICAM-1 in maternal serum and amniotic fluid as an early marker of preeclampsia and IUGR. Baviera G, D'Anna R, Corrado F, Ruello A, Buemi M, Jasonni VM. J Reprod Med; 2002 Mar; 47(3):191-3. PubMed ID: 11933682 [Abstract] [Full Text] [Related]
29. Prediction and prevention of preeclampsia and IUGR. Fayyad AM, Harrington KF. Early Hum Dev; 2005 Nov; 81(11):865-76. PubMed ID: 16289644 [Abstract] [Full Text] [Related]
30. Homeostatic model assessment and risk for hypertension during pregnancy: a longitudinal prospective study. Romero-Gutiérrez G, Malacara JM, Amador N, Fierro-Martínez C, Muñoz-Guevara LM, Molina-Rodríguez R. Am J Perinatol; 2004 Nov; 21(8):455-62. PubMed ID: 15580541 [Abstract] [Full Text] [Related]
34. [Minutes of the 1st national symposium on hypertensive disorders in pregnancy]. Yang Z, Lin JH, Feng SL. Zhonghua Fu Chan Ke Za Zhi; 2009 Feb; 44(2):84-6. PubMed ID: 19570414 [No Abstract] [Full Text] [Related]
37. Development of early non-invasive markers and means for the diagnosis and progression monitoring of preeclampsia and tailoring putative therapies (project pregenesys 037244). Meiri H, Huppertz B, Cetin I. Placenta; 2011 Feb; 32 Suppl():S1-3. PubMed ID: 21257078 [No Abstract] [Full Text] [Related]